Showing results (91-100 of 351) with videos related to
Sort By:
Pageof 36
Oncology|August 31, 2023
Favorable Impact of Serum TERT C228T for Prognosis after Surgical Resection for Liver CancerNorio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, et al.Journal of Gastroenterology and Hepatology|March 3, 2005
Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis BAkihito Tsubota, Yasuji Arase, Yoshiyuki Suzuki, et al.Journal of Medical Virology|August 21, 2007
Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infectionYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.Japanese Journal of Clinical Oncology|January 3, 2012
Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinomaNorihiro Imai, Kenji Ikeda, Yusuke Kawamura, et al.Journal of Medical Virology|February 17, 2005
Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN-resistant cases with hepatocyte steatosisNorio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.Digestive Diseases and Sciences|April 24, 2004
Effect of acute self-limited hepatitis C virus (HCV) superinfection on hepatitis B virus (HBV)-related cirrhosis. Virological features of HBV-HCV dual infectionNorio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.Internal Medicine (Tokyo, Japan)|August 7, 2007
Serum KL-6 level is elevated in chronic hepatitis C patients with combination therapy of pegylated interferon and ribavirinYasuji Arase, Kenji Ikeda, Yoshiyuki Suzuki, et al.Internal Medicine (Tokyo, Japan)|November 21, 2007
Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-CYasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.Internal Medicine (Tokyo, Japan)|July 17, 2008
Suitable treatment period in patients with virological response during combination therapy of peginterferon and ribavirin for chronic hepatitis CYasuji Arase, Fumitaka Suzuki, Hitomi Sezaki, et al.Intervirology|February 21, 2009
Virological response and hepatocarcinogenesis in lamivudine-resistant hepatitis B virus genotype C patients treated with lamivudine plus adefovir dipivoxilNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.Pageof 36